- Home
- CASI vs RETO Comparison
CASI vs RETO Comparison
Compare CASI & RETO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CASI
- RETO
- Stock Information
- Founded
- CASI 1991
- RETO 1999
- Country
- CASI China
- RETO China
- Employees
- CASI N/A
- RETO N/A
- Industry
- CASI Biotechnology: Pharmaceutical Preparations
- RETO Multi-Sector Companies
- Sector
- CASI Health Care
- RETO Consumer Discretionary
- Exchange
- CASI Nasdaq
- RETO Nasdaq
- Market Cap
- CASI 29.7M
- RETO 24.7M
- IPO Year
- CASI 1996
- RETO 2017
- Fundamental
- Price
- CASI $1.89
- RETO $3.56
- Analyst Decision
- CASI Strong Buy
- RETO
- Analyst Count
- CASI 1
- RETO 0
- Target Price
- CASI $4.00
- RETO N/A
- AVG Volume (30 Days)
- CASI 7.1K
- RETO 19.3K
- Earning Date
- CASI 05-16-2025
- RETO 06-26-2025
- Dividend Yield
- CASI N/A
- RETO N/A
- EPS Growth
- CASI N/A
- RETO N/A
- EPS
- CASI N/A
- RETO N/A
- Revenue
- CASI $31,368,000.00
- RETO $1,828,976.00
- Revenue This Year
- CASI N/A
- RETO N/A
- Revenue Next Year
- CASI N/A
- RETO N/A
- P/E Ratio
- CASI N/A
- RETO N/A
- Revenue Growth
- CASI 8.39
- RETO N/A
- 52 Week Low
- CASI $1.64
- RETO $2.86
- 52 Week High
- CASI $7.67
- RETO $18.20
- Technical
- Relative Strength Index (RSI)
- CASI 47.25
- RETO 51.04
- Support Level
- CASI $1.77
- RETO $3.33
- Resistance Level
- CASI $1.98
- RETO $3.73
- Average True Range (ATR)
- CASI 0.10
- RETO 0.29
- MACD
- CASI 0.01
- RETO -0.01
- Stochastic Oscillator
- CASI 54.55
- RETO 52.70
About CASI CASI Pharmaceuticals Inc.
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.
About RETO ReTo Eco-Solutions Inc.
ReTo Eco-Solutions Inc is a manufacturer and distributor of eco-friendly construction materials and fly-ash, as well as equipment used to produce these eco-friendly construction materials. The company engaged in providing consultation, design, project implementation and construction of urban ecological environments for capturing, controlling and re-using rainwater. It operates through four segments namely Machinery and Equipment sales, Construction materials sales, Municipal Construction Projects, and Technology Consulting and other services. The company earns its revenue from Machinery and Equipment sales segment. Geographically, it derives a majority of its revenue from China.